Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
3.150
+0.050 (1.61%)
Dec 5, 2025, 4:00 PM EST - Market closed
Lipocine Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lipocine stock has a target of 7.00, which predicts a 122.22% increase from the current stock price of 3.15.
Price Target: $7.00 (+122.22%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Lipocine is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +122.22% | Nov 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +153.97% | Aug 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +153.97% | Jun 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +153.97% | Jun 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +153.97% | May 29, 2025 |
Financial Forecast
Revenue This Year
965.94K
from 11.20M
Decreased by -91.37%
Revenue Next Year
637.50K
from 965.94K
Decreased by -34.00%
EPS This Year
-2.00
from -0.00
EPS Next Year
-1.85
from -2.00
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.0M | 892,500 | ||||
| Avg | 965,940 | 637,500 | ||||
| Low | 912,380 | 392,000 |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -91.0% | -7.6% | ||||
| Avg | -91.4% | -34.0% | ||||
| Low | -91.9% | -59.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.06 | -1.42 | |
| Avg | -2.00 | -1.85 | |
| Low | -1.93 | -2.22 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.